HDA - Home

Healthcare Distribution Alliance – Patients Move Us.

+ About
- Role of Distributors
- Membership
- HDA History
- Member Directory
- Staff Directory
- Industry Recognition
- Executive Committee
- Mission and Values
- Board of Directors
- Join HDA
- Councils and Committees
- Careers
- About
  
  Information regarding HDA's history, leadership, mission, values and staff.
+ Issues
- COVID-19 Response
- Reimbursement
- Pharmaceutical Traceability
- Distributor Licensure
- Importation of Prescription Medicines
- Drug Shortages
- Prescription Drug Abuse and Diversion
- Emergency Preparedness
- Taxes
- Grassroots Advocacy
- Issues
  
  HDA reviews key priority issues and advocates on behalf of its pharmaceutical distributor members for standards, public policies and business processes that ensure a safe and efficient supply chain.
+ Events
- Distribution Management Webinar Series
- Traceability Seminar
- Distribution Management Conference and Expo
- PCSC Educational Seminar
- BLC Online
- Webinars
- Annual Board and Membership Meeting
- Speaker Resource Center
- Events
  
  HDA regularly brings members and key healthcare supply chain stakeholders together to share industry information, learn about best practices, and be introduced to new products and services.
+ News
- Press Releases
- Blog
- Testimony
- HDA in the News
  
  Press releases, public testimony executive statements and information on HDA's efforts on behalf of pharmaceutical distributors and the supply chain.
+ Resources
- Publications
- COVID-19 Response
- Health Delivered
- Professional Development
- Webinars
- PCSC
- Allied Against Opioid Abuse
- Annual Report
- Resources
  
  HDA and the HDA Research Foundation produce a variety of resources to enhance the value of the supply chain and increase industry knowledge.

COVID-19 Response

Distributors are rising to the challenge of the pandemic response.

Learn More

The First 90 Days

HDA Research Foundation report finds the Rx supply chain quickly adapted to deliver medicines safely and efficiently during the initial COVID-19 response.

Learn more

2020 Traceability Online Seminar

HDA's trusted DSCSA-focused event will take place virtually on November 2-4.

Learn more

Health Delivered

Distributors are the backbone of the U.S. healthcare industry, saving the system between $33 and $53 billion annually.

Learn More

MEMBER SPOTLIGHT

CuraScript Specialty Distribution (CuraScript SD) provides integrated delivery solutions for the safe and efficient distribution of specialty pharmaceuticals and associated medical supplies.

Learn More

IN THE NEWS

October 26, 2020

US Biopharmaceutical Supply Chain Resilient and Effective During Early COVID-19 Response

October 8, 2020

HDA Releases Policy Principles for COVID-19 Vaccine Distribution

October 5, 2020

HDA Announces Robert Mauch and Chad Gielen to Lead Board of Directors

View All News

ISSUES IN DISTRIBUTION

Pharmaceutical Traceability

HDA is now leading industry efforts to implement the 2013 Drug Supply Chain Security Act (DSCSA) that replaced a 50-state patchwork of pedigree requirements with one federal solution to trace prescription...

Prescription Drug Abuse and Diversion

HDA and our primary pharmaceutical distributor members are committed to bringing industry and government together to tackle our nation’s complex prescription drug abuse and diversion epidemic, a serious...

Importation of Prescription Medicines

HDA opposes permitting the importation into the U.S. of pharmaceuticals sold or designated for sale in foreign countries. HDA firmly believes that allowing importation increases the likelihood of counterfeit...

Taxes

HDA opposes repeal of the Last in, First Out (LIFO) accounting method and establishment of gross receipts taxes. Healthcare distribution represents a high-volume, low-profit margin business that is impacted...